The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Erik Renström

Erik Renström

Vice-chancellor

Erik Renström

CaV2.3 calcium channels control second-phase insulin release.

Author

  • Xingjun Jing
  • Dai-Qing Li
  • Charlotta Olofsson
  • Albert Salehi
  • Vikas Surve
  • José Caballero
  • Rosita Ivarsson
  • Ingmar Lundquist
  • Alexey Pereverzev
  • Toni Schneider
  • Patrik Rorsman
  • Erik Renström

Summary, in English

Concerted activation of different voltage-gated Ca2+ channel isoforms may determine the kinetics of insulin release from pancreatic islets. Here we have elucidated the role of R-type CaV2.3 channels in that process. A 20% reduction in glucose-evoked insulin secretion was observed in CaV2.3-knockout (CaV2.3–/–) islets, close to the 17% inhibition by the R-type blocker SNX482 but much less than the 77% inhibition produced by the L-type Ca2+ channel antagonist isradipine. Dynamic insulin-release measurements revealed that genetic or pharmacological CaV2.3 ablation strongly suppressed second-phase secretion, whereas first-phase secretion was unaffected, a result also observed in vivo. Suppression of the second phase coincided with an 18% reduction in oscillatory Ca2+ signaling and a 25% reduction in granule recruitment after completion of the initial exocytotic burst in single CaV2.3–/– ß cells. CaV2.3 ablation also impaired glucose-mediated suppression of glucagon secretion in isolated islets (27% versus 58% in WT), an effect associated with coexpression of insulin and glucagon in a fraction of the islet cells in the CaV2.3–/– mouse. We propose a specific role for CaV2.3 Ca2+ channels in second-phase insulin release, that of mediating the Ca2+ entry needed for replenishment of the releasable pool of granules as well as islet cell differentiation.

Department/s

  • Diabetes - Islet Patophysiology
  • Department of Experimental Medical Science
  • Vascular Physiology
  • Department of Clinical Sciences, Malmö

Publishing year

2005

Language

English

Pages

146-154

Publication/Series

Journal of Clinical Investigation

Volume

115

Issue

1

Document type

Journal article

Publisher

The American Society for Clinical Investigation

Topic

  • Endocrinology and Diabetes

Status

Published

Research group

  • Diabetes - Islet Patophysiology
  • Vascular Physiology

ISBN/ISSN/Other

  • ISSN: 0021-9738